1-4 of 4
Sarah P. Hammond
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Defining infection risk of bispecific antibodies for myeloma

Sarah P. Hammond
Journal: Blood Advances
Blood Adv (2024) 8 (18): 4977–4978.
https://doi.org/10.1182/bloodadvances.2024013813
Published: 2024
Journal Articles

Respiratory infections predominate after day 100 following B-cell maturation antigen–directed CAR T-cell therapy

Jessica S. Little, Megha Tandon, Joseph Seungpyo Hong, Omar Nadeem, Adam S. Sperling, Noopur Raje, Nikhil Munshi, Matthew Frigault, Sara Barmettler, Sarah P. Hammond
Journal: Blood Advances
Blood Adv (2023) 7 (18): 5485–5495.
https://doi.org/10.1182/bloodadvances.2023010524
Published: 2023
Journal Articles

Low incidence of invasive fungal disease following CD19 chimeric antigen receptor T-cell therapy for non-Hodgkin lymphoma

Jessica S. Little, Muneerah M. Aleissa, Katherine Beluch, Isabel H. Gonzalez-Bocco, Francisco M. Marty, Jennifer Manne-Goehler, Sophia Koo, Sarah P. Hammond, Caron A. Jacobson
Journal: Blood Advances
Blood Adv (2022) 6 (16): 4821–4830.
https://doi.org/10.1182/bloodadvances.2022007474
Published: 2022
Journal Articles

Antiviral prophylaxis for cytomegalovirus infection in allogeneic hematopoietic cell transplantation

Clinical Trials & Observations
Kaiwen Chen, Matthew P. Cheng, Sarah P. Hammond, Hermann Einsele, Francisco M. Marty
Journal: Blood Advances
Blood Adv (2018) 2 (16): 2159–2175.
https://doi.org/10.1182/bloodadvances.2018016493
Published: 2018
Includes: Supplemental data